
### [NCIT:C6528](http://purl.obolibrary.org/obo/NCIT_C6528)
**Label:** Pericytic Neoplasm

**Subclasses:** [NCIT:C49110](http://purl.obolibrary.org/obo/NCIT_C49110) (Solid Angioleiomyoma), [NCIT:C51133](http://purl.obolibrary.org/obo/NCIT_C51133) (Solid Glomus Tumor), [NCIT:C27497](http://purl.obolibrary.org/obo/NCIT_C27497) (Glomus Tumor of Uncertain Malignant Potential), [NCIT:C6529](http://purl.obolibrary.org/obo/NCIT_C6529) (Benign Pericytic Neoplasm), [NCIT:C6748](http://purl.obolibrary.org/obo/NCIT_C6748) (Benign Glomus Tumor), [NCIT:C49115](http://purl.obolibrary.org/obo/NCIT_C49115) (Cavernous Angioleiomyoma), [NCIT:C27496](http://purl.obolibrary.org/obo/NCIT_C27496) (Glomangiomatosis), [NCIT:C3742](http://purl.obolibrary.org/obo/NCIT_C3742) (Myofibromatosis), [NCIT:C6530](http://purl.obolibrary.org/obo/NCIT_C6530) (Malignant Pericytic Neoplasm), [NCIT:C6750](http://purl.obolibrary.org/obo/NCIT_C6750) (Cutaneous Glomangioma), [NCIT:C4221](http://purl.obolibrary.org/obo/NCIT_C4221) (Malignant Glomus Tumor), [NCIT:C3060](http://purl.obolibrary.org/obo/NCIT_C3060) (Glomus Tumor), [NCIT:C5355](http://purl.obolibrary.org/obo/NCIT_C5355) (Intravascular Angioleiomyoma), [NCIT:C4222](http://purl.obolibrary.org/obo/NCIT_C4222) (Glomangioma), [NCIT:C4491](http://purl.obolibrary.org/obo/NCIT_C4491) (Glomus Tumor of the Skin), [NCIT:C5350](http://purl.obolibrary.org/obo/NCIT_C5350) (Hereditary Glomangioma), [NCIT:C6480](http://purl.obolibrary.org/obo/NCIT_C6480) (Bone Glomus Tumor), [NCIT:C7052](http://purl.obolibrary.org/obo/NCIT_C7052) (Myofibroma), [NCIT:C95900](http://purl.obolibrary.org/obo/NCIT_C95900) (Gastric Glomus Tumor), [NCIT:C3747](http://purl.obolibrary.org/obo/NCIT_C3747) (Angioleiomyoma), 

**Class expressions from DL-Learner:**

- [NCIT:C41839](http://purl.obolibrary.org/obo/NCIT_C41839) (Perivascular Arrangement of Tumor Cells) 75.00%
- [CL:0000669](http://purl.obolibrary.org/obo/CL_0000669) (pericyte cell) 75.00%
- Thing 50.92%
- [CL:0000630](http://purl.obolibrary.org/obo/CL_0000630) (supportive cell) 47.36%
- [CL:0000183](http://purl.obolibrary.org/obo/CL_0000183) (contractile cell) 37.13%
- [CL:0002320](http://purl.obolibrary.org/obo/CL_0002320) (connective tissue cell) 35.21%
- [CL:0002371](http://purl.obolibrary.org/obo/CL_0002371) (somatic cell) 28.05%
- [CL:0000548](http://purl.obolibrary.org/obo/CL_0000548) (animal cell) 27.97%
- [CL:0000255](http://purl.obolibrary.org/obo/CL_0000255) (eukaryotic cell) 27.97%
- [CL:0000003](http://purl.obolibrary.org/obo/CL_0000003) (native cell) 27.76%
- [GO:0005623](http://purl.obolibrary.org/obo/GO_0005623) (cell) 27.76%
- [CL:0000000](http://purl.obolibrary.org/obo/CL_0000000) (cell) 27.72%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 27.56%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 26.78%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 26.36%


